News

GelSana Therapeutics, completes SBDC’s first-ever virtual Tech Venture Accelerator for Women

DENVER — Yesterday, the Colorado Small Business Development Center (SBDC) Network’s statewide TechSource program completed its first-ever virtual Tech Venture Accelerator for Women (TVX-W). Ten female-owned, Colorado-based technology businesses were chosen for the program based on their proposals for Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR), and their potential for commercialization.  The ten participants of the programContinue reading “GelSana Therapeutics, completes SBDC’s first-ever virtual Tech Venture Accelerator for Women”

About GelSana

What We Do The healing of wounds can be difficult for some patients, particularly where chronic inflammation and increased oxidative stress are involved in the wound healing impairment. Hydrogels are promising materials as wound healing dressings, particularly if they remain adhered to the wound and could also release therapeutic factors to the wound bed overContinue reading “About GelSana”

Innosphere Ventures “Funded in Colorado” episode with founder & CEO of GelSana Therapeutics, Melissa Krebs, PhD

In this “Funded in Colorado” episode, Innosphere’s CEO Mike Freeman sits down with Melissa Krebs, PhD, founder and CEO of GelSana Therapeutics, a Colorado-based MedTech company that is developing novel hydrogels that heal wounds faster and with less inflammation, to talk about her recent experience in raising pre-seed capital for her University-based company.GelSana is an Innosphere FundContinue reading “Innosphere Ventures “Funded in Colorado” episode with founder & CEO of GelSana Therapeutics, Melissa Krebs, PhD”

Mines professor receives pre-seed funding to develop hydrogel bandage technology

Melissa Krebs will use the funding from Innosphere Ventures to accelerate GelSana Therapeutics’ product development plan A biotech startup company founded by a Mines professor has received pre-seed funding to help commercialize hydrogel bandages capable of slowly releasing medication. GelSana Therapeutics will use the funding from Innosphere Ventures to accelerate its product development plan, saidContinue reading “Mines professor receives pre-seed funding to develop hydrogel bandage technology”

Management Team

Melissa Krebs, Ph.D. Founder & CEO Associate Professor, Colorado School of Mines 22 years research experience

Matthew Davidson, Ph.D. Senior Scientist 10 years research experience.

Markets
  • Wound care
  • Diabetic wound care
  • Dermal adhesives
Subscribe

Get new content delivered directly to your inbox.